Study discovers triple immunotherapy combination as possible treatment for pancreatic cancer
Updated: 2022-12-30 16:00:00
Researchers at The University of Texas MD Anderson Cancer Center have discovered a novel immunotherapy combination, targeting checkpoints in both T cells and myeloid suppressor cells, that successfully reprogrammed the tumor immune microenvironment (TIME) and significantly improved anti-tumor responses in preclinical models of pancreatic cancer. 
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.